JW Asset Management
JW Asset Management is a registered investment adviser based in New York, founded in 1998. The firm specializes in managing hedge funds and private equity funds, with a primary focus on investments in the healthcare sector, alongside interests in pharmaceuticals, agtech, banking, cannabis, consumer products, retail, and wellness. JW Asset Management employs various investment strategies, including sector-oriented equity and event-driven approaches, while maintaining exposure to equities, derivatives, and both corporate and sovereign fixed income. The firm has demonstrated its capabilities through significant investments, such as leading the acquisition of Arbor Pharmaceuticals and serving as the lead investor in TerrAscend Corp.
Establishment Labs
Debt Financing in 2016
Establishment Labs S.A. is a medical technology company based in Alajuela, Costa Rica, that specializes in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants. The company's flagship product line, Motiva Implants, features a variety of options in surface, shape, size, base, and projection and is sold in over 60 countries. Establishment Labs also offers innovative solutions such as the MotivaImagine application, which aids in surgical planning, and Q Inside Safety Technology, a radio frequency identification transponder that provides surgeons with implant-specific data. Additionally, the company provides Puregraft technology for purified fat reinjection and operates a center for breast augmentation consultations. Its manufacturing facilities comply with FDA and ISO standards, and the company has regulatory offices in the United States and a distribution center in Belgium. Established in 2004, Establishment Labs serves plastic surgeons and patients globally, emphasizing innovation in its product offerings.
Establishment Labs
Venture Round in 2015
Establishment Labs S.A. is a medical technology company based in Alajuela, Costa Rica, that specializes in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants. The company's flagship product line, Motiva Implants, features a variety of options in surface, shape, size, base, and projection and is sold in over 60 countries. Establishment Labs also offers innovative solutions such as the MotivaImagine application, which aids in surgical planning, and Q Inside Safety Technology, a radio frequency identification transponder that provides surgeons with implant-specific data. Additionally, the company provides Puregraft technology for purified fat reinjection and operates a center for breast augmentation consultations. Its manufacturing facilities comply with FDA and ISO standards, and the company has regulatory offices in the United States and a distribution center in Belgium. Established in 2004, Establishment Labs serves plastic surgeons and patients globally, emphasizing innovation in its product offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.